State of New Jersey Common Pension Fund D Boosts Holdings in Intuitive Surgical, Inc. $ISRG

State of New Jersey Common Pension Fund D raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 120,616 shares of the medical equipment provider’s stock after purchasing an additional 356 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Intuitive Surgical were worth $65,544,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Chilton Capital Management LLC raised its position in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical in the first quarter worth about $26,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical in the second quarter worth about $30,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. Finally, TD Capital Management LLC raised its position in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. This represents a 31.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,724 shares of company stock valued at $19,500,332. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Down 0.9%

ISRG opened at $546.51 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a 50-day moving average price of $458.09 and a 200 day moving average price of $497.02. The company has a market cap of $195.91 billion, a PE ratio of 72.29, a price-to-earnings-growth ratio of 5.50 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday. HSBC upped their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research report on Thursday. BTIG Research upped their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research report on Wednesday. The Goldman Sachs Group decreased their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Finally, Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $602.32.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.